Hyaluronic Acid Amide Hydrogel for Faster Bone Mineralization

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing treatments for bone mineralization in patients with osteopenia or osteoporosis are inefficient in promoting rapid and effective ossification, particularly in cases where bone fragility leads to prolonged healing times and increased fracture risk.

Innovation Solution

A pharmaceutical composition comprising hexadecyl amide derivatives of hyaluronic acid, with a specific molecular weight and amidation degree, is administered locally to stimulate mesenchymal cells and enhance bone mineralization, forming a stable hydrogel that remains at the application site.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Speed

If conventional treatments are used for bone mineralization in osteopenic or osteoporotic patients, then the treatment can be administered, but the ossification process is slow and healing times are prolonged

Engineering Contradiction:

Improveossification rateVSAvoidhealing time

Core Design Contradiction:

SpeedVSLoss of time

Solution Approach 1:

The patent modifies the molecular weight parameter of hyaluronic acid to a specific range (500-730 kDa) and introduces amidation modification to create hexadecyl amide derivatives. These parameter changes enhance the biocompatibility and osteogenic activity of the substance, accelerating ossification rate while reducing healing time in osteopenic and osteoporotic patients.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite material by combining hexadecyl amide modification with hyaluronic acid backbone, forming a derivatized polysaccharide with enhanced properties. This composite structure maintains the natural mucoadhesive characteristics of hyaluronic acid while adding osteostimulating activity through the amidation modification.

Inventive Principle:

Principle #40Composite materials

2Productivity

If hyaluronic acid derivatives are used to stimulate bone mineralization, then ossification is enhanced, but the composition must maintain stability at the application site

Engineering Contradiction:

Improvebone mineralization activityVSAvoidcomposition stability

Core Design Contradiction:

ProductivityVSStability of the object's composition

Solution Approach 1:

The hexadecyl amide derivative of hyaluronic acid utilizes its own molecular structure to achieve both stability and activity. The derivatization modifies the molecule to enhance its osteogenic properties while maintaining its natural mucoadhesive characteristics, allowing it to stabilize at the application site through its inherent properties without requiring additional stabilizing agents.

Inventive Principle:

Principle #25Self-service

3Productivity

If mesenchymal cells are stimulated to differentiate into osteoblasts, then bone formation is accelerated, but the process requires specific molecular weight and amidation degree control

Engineering Contradiction:

Improveosteoblast differentiation rateVSAvoidamidation degree control

Core Design Contradiction:

ProductivityVSManufacturing precision

Solution Approach 1:

The patent establishes specific parameter ranges for molecular weight (500-730 kDa) and amidation degree (1-3% m/m) to optimize the balance between manufacturing feasibility and biological activity. These controlled parameter changes ensure consistent osteoblast differentiation rates while maintaining practical manufacturability through defined synthesis protocols.

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition significantly stimulates mesenchymal cell differentiation into osteoblasts, enhances gene expression for extracellular matrix deposition, and accelerates bone mineralization, improving healing times and reducing fracture risk in osteopenic and osteoporotic patients.

Implementation Method 1

forming a stable hydrogel that remains at the application site

Methodology Applied

Scientific EffectHydrogel: Hydrogel

Implementation Method 2

stimulates mesenchymal cell differentiation into osteoblasts

Methodology Applied

Scientific EffectCell differentiation:

Implementation Method 3

enhances gene expression for extracellular matrix deposition

Methodology Applied

Scientific EffectGene expression:

Implementation Method 4

accelerates bone mineralization

Methodology Applied

Scientific EffectMineralization: Deposition (physical)

Data Source

PatentEP3986421B1Pharmaceutical compositions comprising amide derivatives of hyaluronic acid, for use in the treatment of bone traumas, in particular of patients with problems of osteopenia or osteoporosis

Publication Date: 2026.04.01 FIDIA FARM SPA

AI summary

Pharmaceutical compositions are described comprising amide derivatives of hyaluronic acid for use in the treatment of bone mineralization in bone traumas, in particular in patients with problems of osteopenia or osteoporosis. More specifically, these compositions are used in the treatment of bone mineralization in bone fractures, in patients suffering from pathologies characterized by a T- score index lower than -1, preferably lower than -2.5.